HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc., commonly referred to as HTG, is a pioneering company headquartered in the United States, specialising in molecular diagnostics. Founded in 2006, HTG has established itself as a leader in the development of innovative technologies for gene expression profiling and biomarker discovery, primarily serving the oncology and research sectors. The company’s flagship products, including the HTG EdgeSeq platform, offer unique solutions for high-throughput gene expression analysis, enabling precise and efficient data generation. HTG's commitment to advancing personalised medicine has positioned it favourably within the competitive landscape of molecular diagnostics, with notable achievements in enhancing patient outcomes through targeted therapies. With a strong operational presence across key regions in the US, HTG continues to drive advancements in molecular diagnostics, solidifying its reputation as a trusted partner in the healthcare industry.
DitchCarbon Score
How does HTG Molecular Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HTG Molecular Diagnostics, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HTG Molecular Diagnostics, Inc.'s reported carbon emissions
HTG Molecular Diagnostics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that HTG Molecular Diagnostics may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it remains essential for companies like HTG to consider developing and communicating their climate strategies to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HTG Molecular Diagnostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
